BXP, Inc.

BXP, Inc. is the largest publicly-traded office real estate investment trust in the United States, owning and operating a 52.6-million-square-foot portfolio of premier workplaces concentrated in six gateway markets — Boston, Los Angeles, New York, San Francisco, Seattle, and Washington, DC. The company was founded in 1970, went public in 1997, and operates through an UPREIT structure in which BXP, Inc. is the general partner of Boston Properties Limited Partnership, the entity that holds the real estate and employs all 826 staff.

The file you are reading turns on a single structural question: whether BXP's collection of high-barrier-to-entry urban office assets, burdened with $16.6 billion of debt, generates enough internal cash flow growth from rising occupancy and development deliveries to outrun the headwind of refinancing legacy low-coupon debt at today's higher rates. The business itself is straightforward — own irreplaceable buildings in places where it is nearly impossible to build new ones, lease them to creditworthy clients on long-term contracts, and compound value through selective development. The complexity is entirely in the timing: the office market is recovering from its most severe dislocation in a generation, and BXP is simultaneously running a large asset-sale program, funding a multi-billion-dollar development pipeline, and managing a debt maturity wall that will require refinancing roughly $1 billion of 3.5% bonds in October 2026.

A year ago this story would have read as a distress thesis. Today it reads as an occupancy-recovery thesis with a refinancing overhang. Leasing volume is running well above historical averages, in-service occupancy has risen for three consecutive quarters to 88.4%, and new office construction has effectively halted across BXP's markets — a supply picture that, if demand holds, should produce meaningful rent growth in the tightest submarkets. The stock at $72.97 prices about $11.6 billion of equity, implying roughly 14 times trailing EBITDA and a 3.8% dividend yield after last year's reduction. This is not obviously cheap for a leveraged office REIT, nor obviously expensive if the recovery thesis plays out. The rest of this file is about helping you decide which case you believe.